Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 140Leukemia 132Lymphoma 90Leukemia, Myeloid, Acute 62Myelodysplastic Syndromes 47Burkitt Lymphoma 46Lymphoma, Non-Hodgkin 44Lymphoma, Large B-Cell, Diffuse 37Breast Neoplasms 37Lymphoma, Mantle-Cell 33Leukemia, Lymphocytic, Chronic, B-Cell 33Hodgkin Disease 32Multiple Myeloma 29Congenital Abnormalities 29Myeloproliferative Disorders 27Lymphoma, Follicular 27Leukemia, Myeloid, Accelerated Phase 27Graft vs Host Disease 27Leukemia, Myelomonocytic, Chronic 25Lymphoma, Large-Cell, Immunoblastic 24Leukemia, Myeloid, Chronic-Phase 24Blast Crisis 24Lymphoma, B-Cell, Marginal Zone 22Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20Anemia, Refractory, with Excess of Blasts 20Recurrence 18Primary Myelofibrosis 17Neoplasms, Plasma Cell 17Dendritic Cell Sarcoma, Interdigitating 17Osteosarcoma 16

Interventions

Peripheral Blood Stem Cell Transplantation 4Epoetin Alfa 3Darbepoetin alfa 3Cyclophosphamide 3liposomal amphotericin B 2fludarabine phosphate 2Microarray Analysis 2Methylprednisolone 2Interferon-alpha 2In Situ Hybridization, Fluorescence 2Filgrastim 2Cytogenetic Analysis 2Cyclosporine 2Caspofungin 2Bortezomib 2Antilymphocyte Serum 2tanespimycin 1siltuximab 1pyroxamide 1piperine 1ibrutinib 1ferrous sulfate 1ferric gluconate 1aldesleukin 1Whole-Body Irradiation 1Watchful Waiting 1Urination 1Topotecan 1Therapeutics 1Tacrolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Monoclonal Gammopathy of Undetermined Significance × Methotrexate × Clear all
NCT00245037 2017-09-27

Bu Flu TBI

OHSU Knight Cancer Institute

Phase 1/2 Completed
147 enrolled 19 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡